Combined with the results of MAMs microstructure and Ca2+ levels, it can be inferred that the mechanism of YQHX in treating MI may be through regulating Ca2+ flux on MAMs via Sig-1R, improving the structure of MAMs, and subsequently improving cardiac function, exerting a cardioprotective effect. Here, SIGMAR1 is linked to myocardial infarction.